These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 16431341
41. Normotensive scleroderma renal crisis in a patient with progressive systemic sclerosis: case report and review of literature. Saeed F, Parke A. Conn Med; 2011 Feb; 75(2):83-7. PubMed ID: 21476377 [Abstract] [Full Text] [Related]
45. The role of DMARDs in systemic sclerosis therapy. Blank N, Max R, Lorenz HM. Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii42-4. PubMed ID: 16987834 [Abstract] [Full Text] [Related]
49. [Immunopathological disturbances in systemic sclerosis]. Gindzieńska-Sieśkiewicz E, Klimiuk PA, Kowal-Bielecka O, Sierakowski S. Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427 [Abstract] [Full Text] [Related]
50. [Systemic sclerosis: different subsets and disease remitting drugs]. Ogawa T, Saito E. Nihon Rinsho; 1999 Feb; 57(2):344-8. PubMed ID: 10078002 [Abstract] [Full Text] [Related]
51. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis. Casale R, Generini S, Luppi F, Pignone A, Matucci-Cerinic M. Arthritis Rheum; 2004 Aug 15; 51(4):665-9. PubMed ID: 15334442 [No Abstract] [Full Text] [Related]
54. [Current treatment of systemic sclerosis. Part II. Vascular and antifibrotic treatment]. Sicińska J, Rudnicka L. Pol Merkur Lekarski; 2008 Aug 15; 25(146):196-200. PubMed ID: 18942347 [Abstract] [Full Text] [Related]
55. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study. Vonk MC, Broers B, Heijdra YF, Ton E, Snijder R, van Dijk AP, van Laar JM, Bootsma H, van Hal PT, van den Hoogen FH, van Daele PL. Ann Rheum Dis; 2009 Jun 15; 68(6):961-5. PubMed ID: 18511546 [Abstract] [Full Text] [Related]
56. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease. Mittoo S, Wigley FM, Wise R, Xiao H, Hummers L. Arthritis Rheum; 2007 Dec 15; 56(12):4195-202. PubMed ID: 18050251 [Abstract] [Full Text] [Related]
58. New pathogenic and therapeutic concepts in systemic sclerosis. Hügle T, Huigens CA, van Laar JM. Arzneimittelforschung; 2009 Dec 15; 59(12):615-24. PubMed ID: 20108646 [Abstract] [Full Text] [Related]
59. [Scleroderma renal crisis]. Teixeira L, Servettaz A, Mehrenberger M, Noël LH, Guillevin L, Mouthon L. Presse Med; 2006 Dec 15; 35(12 Pt 2):1966-74. PubMed ID: 17159723 [Abstract] [Full Text] [Related]